| Revenue growth | 20% YoY for FY26; 34% for Q4 FY26. |
|---|---|
| Margins | Gross margin expanded to 7.5% (FY26) from 6.5% (FY25). |
| Demand visibility | Strong, scaling to 62K retail pharmacies and 50k+ SKUs. |
| Management confidence | High, targeting 30%+ CAGR over 5 years. |
Growth
FY26 revenue reached ₹1,306cr (+20% YoY); Gross Profit grew 38% to ₹98cr. Q4 revenue grew 34.1% YoY.
Outlook
Strategic 30%+ CAGR priority for next 5 years; expansion into 6 total fulfillment centers and wellness/beauty categories.
Risks
Net loss of ₹1.4cr for FY26; negative EBITDA margins of -5.0%. Heavy reliance on supply chain segment.
Earnings Call filed with BSE, NSE: HEALTHX. Summary written with AI assistance from the document.
Health X Platform Ltd: key numbers
- Share price
- ₹286.45
- Market cap
- ₹911.2 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -45.1×Sector 53.1×
- Promoter holding
- 74.07%-0.77% QoQ
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Annual General Meeting
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Health X Platform Investor Presentation: Key Takeaways
Health X Platform reports strong Q1 FY27 growth with revenue at ₹440.3 Cr and 7.8% gross margins, leveraging its B2C SastaSundar and B2B Retailer Shakti ecosystems.
- Call
- Guides 30% growth
Health X Platform Management Change
Health X Platform Limited has re-appointed Anjana Dikshit as a Non-Executive Independent Director for a 60-month term, effective November 10, 2026.